|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn881510317 |
003 |
OCoLC |
005 |
20231120111610.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
140620s2014 mau ob 000 0 eng d |
040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d CDX
|d OPELS
|d EBLCP
|d N$T
|d E7B
|d OCLCF
|d OCLCQ
|d DEBSZ
|d OCLCO
|d DIBIB
|d OCLCO
|d OCLCQ
|d OCLCO
|d ITD
|d OCLCQ
|d BUF
|d OCLCQ
|d U3W
|d D6H
|d OTZ
|d OCLCQ
|d AUD
|d OCLCQ
|d S2H
|d OCLCO
|d UX1
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 881571052
|
020 |
|
|
|a 1306874661
|q (electronic bk.)
|
020 |
|
|
|a 9781306874663
|q (electronic bk.)
|
020 |
|
|
|a 9780080999395
|q (electronic bk.)
|
020 |
|
|
|a 0080999395
|q (electronic bk.)
|
020 |
|
|
|a 9780080999401
|q (electronic bk.)
|
020 |
|
|
|a 0080999409
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)881510317
|z (OCoLC)881571052
|
050 |
|
4 |
|a QD321
|
060 |
|
4 |
|a 2015 E-754
|
060 |
|
4 |
|a QU 83
|
072 |
|
7 |
|a SCI
|x 013060
|2 bisacsh
|
072 |
|
7 |
|a TEC
|x 009010
|2 bisacsh
|
082 |
0 |
4 |
|a 610.3
|b 23
|
100 |
1 |
|
|a Khor, Eugene.
|
245 |
1 |
0 |
|a Chitin :
|b fulfilling a biomaterials promise /
|c by Eugene Khor ; with Andrew C.A. Wan.
|
250 |
|
|
|a 2nd ed.
|
264 |
|
1 |
|a Waltham, MA :
|b Elsevier,
|c 2014.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a The second edition of Chitin underscores the important factors for standardizing chitin processing and characterization. It captures the essential interplay between chitin's assets and limitations as a biomaterial, placing the past promises of chitin in perspective, addressing its present realities and offering insight into what is required to realize chitin's destiny (including its derivative, chitosan) as a biomaterial of the twenty-first century. This book is an ideal guide for both industrialists and researchers with a vested interest in commercializing chitin.
|
504 |
|
|
|a Includes bibliographical references.
|
504 |
|
|
|a References6 Chitin and Chitosan Relative to Collagen and Hyaluronan; 6.1 Preliminary comments; 6.2 Brief overview of collagen; 6.3 Brief overview of hyaluronan; 6.4 Survey of chitin with collagen and hyaluronan; 6.4.1 Chitosan and collagen; 6.4.2 Chitosan and HA; 6.4.3 Chitosan with collagen and HA; 6.5 Trends; References; 7 Chitin and Chitosan: Making the Grade; 7.1 What is Medical Grade?; 7.2 Obtaining ready-to-use materials7; 7.2.1 Chitin raw materials; 7.2.2 Chitin pretreatment; 7.2.3 Chitin isolation; 7.3 Purity and quality; 7.3.1 Criteria for acceptance-purity.
|
505 |
0 |
|
|a Front Cover; Chitin: Fulfilling a Biomaterials Promise; Copyright Page; Contents; Acknowledgments; About the Author; Background; Preface to the Second Edition; Format; Comments on literature survey and references; Preface to the First Edition; 1 Overview of Chitin and Chitosan Research; 1.1 The Golden Era; 1.2 Generational transition; 1.3 Key outcomes of chitin and chitosan research to date; 1.3.1 Production of raw materials; 1.3.2 Characterization and structural studies; 1.3.3 Chemistry; 1.3.4 Nonbiomedical applications; 1.3.4.1 Industrial; 1.3.4.2 Waste treatment/heavy metal recovery.
|
505 |
8 |
|
|a 1.3.4.3 Crops and food preservation1.4 Trends; 1.4.1 Toward ready-to-use; 1.4.2 Toward quantitative determinations; 1.4.3 Toward versatility in properties; 1.4.4 Toward commercial applications; Summary; References; 2 Chitosan Biomedical Commercialization; 2.1 Preliminary comments; 2.2 Survey of commercial chitin/chitosan enterprises: demise, disputes, perennials, and new players; 2.2.1 BioSyntech; 2.2.2 Hemcon; 2.2.3 MPT; 2.2.4 Medovent; 2.2.5 Novamatrix-FMC Biopolymer; 2.2.6 Heppe medical chitosan GmbH; 2.2.7 Kitozyme; 2.2.8 Chinese producers.
|
505 |
8 |
|
|a 2.2.8.1 Qingdao Hong Hai Bio-Tech Co., Ltd. and Qingdao BZ Oligo Biotech Co., Ltd. 2.2.8.2 Zhejiang Ao Xing Biotechnology Co., Ltd.; 2.2.9 Other chitin producers; 2.3 Trends; 2.3.1 Commercial outlook; 2.3.2 Research implications; Summary; References; 3 Traditional Chitin and Chitosan Biomaterials Research; 3.1 Preliminary comments; 3.2 Survey; 3.2.1 Wound dressings; 3.2.2 Bone substitutes; 3.2.3 Blood interactions; 3.2.4 Chitosan as the carrier/delivery system for pharmaceuticals and biological materials; 3.2.5 Antimicrobial agents; 3.3 Trends; References.
|
505 |
8 |
|
|a 4 Chitin and Chitosan Tissue Engineering and Stem Cell Research4.1 Preliminary comments; 4.2 Survey; 4.2.1 TE overview; 4.2.2 TE survey; 4.2.3 SC survey; 4.3 Trends; 4.3.1 Biomaterials/scaffolds technology going forward; 4.3.2 Technology, product development, and manufacturing; 4.3.3 TE and SC regulatory perspective; 4.3.4 What now for chitin?; References; 5 The Impact of Nanotechnology on Chitin and Chitosan Biomaterials Research; 5.1 Preliminary comments; 5.2 Survey; 5.2.1 Nanofibers; 5.2.2 Nanoparticles; 5.2.3 Nanocombinations; 5.2.4 Biomedical applications that utilize chitin; 5.3 Trends.
|
650 |
|
0 |
|a Chitin
|x Biotechnology.
|
650 |
|
6 |
|a Chitine
|0 (CaQQLa)201-0065330
|x Biotechnologie.
|0 (CaQQLa)201-0378829
|
650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Industrial & Technical.
|2 bisacsh
|
650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Chemical & Biochemical.
|2 bisacsh
|
650 |
|
7 |
|a Chitin
|x Biotechnology
|2 fast
|0 (OCoLC)fst00857992
|
700 |
1 |
|
|a Wan, Andrew C. A.
|
776 |
0 |
8 |
|i Print version:
|z 9781306874663
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080999395
|z Texto completo
|